FORESITE CAPITAL
FORESITE CAPITAL is a Seed, Series A, Series B and Series C+ fund in the US and Global writing $50M–$120M checks into AI, Healthcare and DeepTech.
- Stages
- Seed, Series A, Series B, Series C+
- Sectors
- AI, Healthcare, DeepTech
- Check size
- $50M–$120M
- Invests in
- US-wide, Global
- Round role
- Leads and follows
- Actively investing
- Yes
- Founded
- 2011
- Assets under management
- $3.5B
- Website
- foresitecapital.com
Thesis
Foresite Capital operates under a highly specialized investment thesis centered on the long-term convergence of data science, machine learning, and biotechnology. The firm systematically targets deep innovation in three core areas: precision therapeutics, life science infrastructure, and healthcare delivery models. Foresite believes that advanced computational algorithms and genomics have permanently altered the efficiency of therapeutic discovery. Their investment structure splits focus evenly, allocating 50% of capital to incubation or early-stage ventures and 50% to late-stage scale-ups and growth equity. Through its internal incubator, Foresite Labs, the firm works closely with elite academic, clinical, and data science teams to conceptualize and scale businesses from the ground up. To be a strong structural fit, a candidate company must demonstrate rigorous scientific validation alongside a business model built around technical data infrastructure. Foresite aims to act as a critical operational partner from proof-of-concept through to IPO, relying on a deeply integrated multi-disciplinary team of MDs, PhDs, and seasoned financial operators to derisk regulatory and clinical hurdles faster than standard generalist venture firms.
Common questions
Does FORESITE CAPITAL invest at the Seed stage?
Yes. FORESITE CAPITAL lists Seed, Series A, Series B and Series C+ among the stages it invests in.
What check size does FORESITE CAPITAL write?
FORESITE CAPITAL writes $50M–$120M checks.
Where does FORESITE CAPITAL invest?
FORESITE CAPITAL invests in the US and Global.